冷血照射基托:直接通往选择性抗瘤治疗的途径
Camelia Miron1, Bianca Andreica2, Manuela M Iftime2
1Center for Low-temperature Plasma Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.
International journal of biological macromolecules
|October 17, 2024
概括
血激活基托 (PAC) 显示选择性杀死癌细胞. 这种生物相容的抗瘤系统来自冷大气等离子体,为癌症治疗提供了一个有前途的新途径.
科学领域:
- 生物材料科学 生物材料科学
- 等离子体物理学的物理学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 酸盐是一种有前途的生物材料,用于药物输送和组织工程.
- 开发有效和生物相容的癌症治疗系统仍然是一个关键的挑战.
研究的目的:
- 研究用于癌症治疗的血激活基托 (PAC) 合体的生产.
- 评估PAC的细胞毒性作用,生物相容性和功能性质.
主要方法:
- 用冷大气等离子体在中或//氧混合物中照射素溶液.
- 使用EPR,LC-MS/MS,XRD,DLS和TGA进行结构和化学分析.
- 评估了体外细胞毒性 (MCF-7,MCF-10A),体外血解以及体内生物相容性 (小鼠).
主要成果:
- PAC对人类乳腺癌细胞 (MCF-7) 具有选择性细胞毒性,而不会损害正常的乳腺上皮细胞 (MCF-10A).
- 细胞毒性作用与基托醇糖和像甘油酸这样的协同化合物有关.
- 在小鼠中,PAC表现出改善的抗氧化活性和粘粘性,具有保存的血液相容性和优异的体内生物相容性.
结论:
- 冷血激活是生产生物相容的基托基抗瘤系统的有效方法.
- PAC为向癌症治疗提供了一个新且安全的平台.
更多相关视频
07:47Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
Published on: December 13, 2015
9.0K
05:26Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
3.3K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
